Skip to main content

Navigation group

Type at least 3 characters
267 articles

Articles

Original Research

Published on 04 Apr 2022

Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy

in Cell and Gene Therapy

  • Agnes Bonifacius
  • Sabine Tischer-Zimmermann
  • Maria Michela Santamorena
  • Philip Mausberg
  • Josephine Schenk
  • Stephanie Koch
  • Johanna Barnstorf-Brandes
  • Nina Gödecke
  • Jörg Martens
  • Lilia Goudeva
Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy
Frontiers in Bioengineering and Biotechnology
doi 10.3389/fbioe.2022.867042
  • 3,558 views
  • 10 citations